← All companies
CRISPR Therapeutics AG
CRSP - Company ID 0001674416
Market cap$5.43 B
Rank#1356
Filings837
Market capitalization of CRISPR Therapeutics AG
As of 2026-07-10, CRISPR Therapeutics AG (CRSP) has a market capitalization of $5.43 B, making it the #1356 most valuable US-listed company.
Recent market cap readings
| Date | Market cap |
|---|---|
| 2026-07-10 | $5.43 B |
| 2026-07-09 | $5.43 B |
| 2026-07-08 | $5.69 B |
| 2026-07-07 | $5.88 B |
| 2026-07-06 | $5.97 B |
| 2026-07-05 | $5.79 B |
| 2026-07-04 | $5.79 B |
| 2026-07-03 | $5.79 B |
| 2026-07-02 | $5.79 B |
| 2026-07-01 | $5.39 B |
| 2026-06-30 | $5.29 B |
| 2026-06-29 | $5.43 B |
Market Cap of similar companies
Frequently asked questions
What is CRISPR Therapeutics AG's market cap?
As of 2026-07-10, CRISPR Therapeutics AG (CRSP) has a market capitalization of $5.43 B, making it the #1356 most valuable US-listed company.
Where does CRISPR Therapeutics AG rank by market cap?
CRISPR Therapeutics AG is the #1356 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.